LENZ Therapeutics rugi bersih GAAP Q2 FY26 melebar jadi USD 31,9 juta; revenue naik jadi USD 5,49 juta

Reuters2026/08/11 20:12

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Lenz Therapeutics membukukan revenue kuartal II 2026 sebesar $5,49 juta, ditopang penjualan VIZZ $1,74 juta.
Rugi bersih melebar menjadi $31,92 juta, atau $1,02 per saham, dari $14,91 juta, atau $0,53 per saham, setahun lalu.
SG&A melonjak menjadi $39,38 juta dari $12,8 juta, dipicu investasi peluncuran termasuk pemasaran, iklan, infrastruktur penjualan, perekrutan.
Penjualan VIZZ mencapai sekitar 27.000 pack, naik 9% dibanding kuartal I 2026; kas dan sekuritas pasar $220 juta per 30 Juni 2026.
Telehealth diluncurkan Juli 2026; CEO Eef Schimmelpennink menyoroti >60% pasien ePharmacy membeli lebih dari satu pack.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lenz Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608111605PRIMZONEFULLFEED9808000) on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

LENZ Therapeutics rugi bersih GAAP Q2 FY26 melebar jadi USD 31,9 juta; revenue naik jadi USD 5,49 juta

You may also like

Crypto prices